The global urine monitoring systems market was valued at USD 5.6 billion in 2024 and is anticipated to reach USD 13.9 billion by 2037, registering a CAGR of 7.1% over the forecast period from 2025 to 2037. By 2025, the market size is expected to reach USD 6.0 billion due to their increasing adoption in managing chronic conditions such as kidney-related disorders, diabetes, and urinary infections. Therefore, patients and healthcare providers will be more inclined toward real-time monitoring solutions that can provide accurate and continuous data to facilitate timely clinical interventions.
Table of Contents
1. Introduction
1.1. Study Objective
1.2. Scope of the report
1.3. Market Taxonomy
1.2. Scope of the report
1.3. Market Taxonomy
2. Study Assumptions and Abbreviations
2.1. Research Methodology
2.2. Secondary Research
2.3. Primary Research
2.4. SPSS Approach
2.5. Data Triangulation
2.2. Secondary Research
2.3. Primary Research
2.4. SPSS Approach
2.5. Data Triangulation
4. Global Industry Overview
4.1. Market Overview
4.2. Regional Synopsis
4.3. Industry Supply Chain Analysis
4.4. DROT
4.4.1. Driver
4.4.2. Restraint
4.4.3. Opportunities
4.4.4. Trends
4.5. Government Regulation: How they would Aid the Business?
4.6. Competitive Landscape
4.6.1. Accuryn Medical
4.6.2. BECTON, DICKINSON AND COMPANY
4.6.3. Beckman Coulter, Inc.
4.6.4. Cardinal Health
4.6.5. DiaSys Diagnostics India Pvt Ltd
4.6.6. F. Hoffmann-La Roche Ltd
4.6.7. FIZE Medical
4.6.8. Hollister Incorporated
4.6.9. Laborie
4.6.10. Siemens Healthcare Private Limited
4.6.11. Sysmex Corporation
4.6.12. Teleflex Incorporated
4.7. Sensica Overview & Market Insights
4.8. Key Trends in Installation & Impact on The Urine Monitoring System Market
4.9. Ongoing Technological Advancements
4.10. Price Benchmarking
4.11. SWOT Analysis
4.12. Product Type Analysis
4.13. Root Cause Analysis (RCA) for Urine Monitoring Systems Market
4.14. Patent Analysis
4.15. Key Development Analysis
4.16. Industry Risk Assessment
4.2. Regional Synopsis
4.3. Industry Supply Chain Analysis
4.4. DROT
4.4.1. Driver
4.4.2. Restraint
4.4.3. Opportunities
4.4.4. Trends
4.5. Government Regulation: How they would Aid the Business?
4.6. Competitive Landscape
4.6.1. Accuryn Medical
4.6.2. BECTON, DICKINSON AND COMPANY
4.6.3. Beckman Coulter, Inc.
4.6.4. Cardinal Health
4.6.5. DiaSys Diagnostics India Pvt Ltd
4.6.6. F. Hoffmann-La Roche Ltd
4.6.7. FIZE Medical
4.6.8. Hollister Incorporated
4.6.9. Laborie
4.6.10. Siemens Healthcare Private Limited
4.6.11. Sysmex Corporation
4.6.12. Teleflex Incorporated
4.7. Sensica Overview & Market Insights
4.8. Key Trends in Installation & Impact on The Urine Monitoring System Market
4.9. Ongoing Technological Advancements
4.10. Price Benchmarking
4.11. SWOT Analysis
4.12. Product Type Analysis
4.13. Root Cause Analysis (RCA) for Urine Monitoring Systems Market
4.14. Patent Analysis
4.15. Key Development Analysis
4.16. Industry Risk Assessment
5. Gobal Outlook and Projections
5.1. Global Overview
5.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
5.1.2. Increment $ Opportunity Assessment, 2024-2037
5.1.3. Year-on-Year Growth Forecast (%)
5.2. Global Segmentation (USD Million), 2024-2037, By
5.2.1. Product Type, Value (USD Million)
5.2.1.1. Urine Output Monitoring Systems
5.2.1.1.1. Automated Urine Output Monitors
5.2.1.1.2. Manual Urine Output Monitors
5.2.1.1.3. Smart Urine Output Monitoring Devices
5.2.1.2. Urine Analysis Monitoring Systems
5.2.1.2.1. Automated Urine Analyzer
5.2.1.2.2. Semi-Automated Urine Analyzer
5.2.1.2.3. Point-of-Care Urine Analyzer
5.2.1.2.4. Non-Invasive Urine Monitoring System
5.2.1.3. Urine Collection Devices
5.2.1.3.1. Urine Collection Bags
5.2.1.3.2. Urinary Catheter
5.2.1.3.3. Others
5.2.2. Usage, Value (USD Million)
5.2.2.1. Urine Collection Bags
5.2.2.1.1. Disposable
5.2.2.1.2. Reusable
5.2.2.2. Urine Catheter
5.2.2.2.1. Disposable
5.2.2.2.2. Reusable
5.2.3. Medical Condition, Value (USD Million)
5.2.3.1. Chronic Kidney Disease (CKD)
5.2.3.2. Acute Kidney Injury
5.2.3.3. Post-Surgical & Intensive Care
5.2.3.4. Sepsis and Shock
5.2.3.5. Others
5.2.4. End user, Value (USD Million)
5.2.4.1. Hospital & Clinics
5.2.4.2. Diagnostic Laboratories
5.2.4.3. Others
5.2.5. Regional Synopsis (USD Million), 2024-2037
5.2.5.1. North America, Value (USD Million)
5.2.5.2. Europe, Value (USD Million)
5.2.5.3. Asia Pacific, Value (USD Million)
5.2.5.4. Latin America, Value (USD Million)
5.2.5.5. Middle East and Africa, Value (USD Million)
5.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
5.1.2. Increment $ Opportunity Assessment, 2024-2037
5.1.3. Year-on-Year Growth Forecast (%)
5.2. Global Segmentation (USD Million), 2024-2037, By
5.2.1. Product Type, Value (USD Million)
5.2.1.1. Urine Output Monitoring Systems
5.2.1.1.1. Automated Urine Output Monitors
5.2.1.1.2. Manual Urine Output Monitors
5.2.1.1.3. Smart Urine Output Monitoring Devices
5.2.1.2. Urine Analysis Monitoring Systems
5.2.1.2.1. Automated Urine Analyzer
5.2.1.2.2. Semi-Automated Urine Analyzer
5.2.1.2.3. Point-of-Care Urine Analyzer
5.2.1.2.4. Non-Invasive Urine Monitoring System
5.2.1.3. Urine Collection Devices
5.2.1.3.1. Urine Collection Bags
5.2.1.3.2. Urinary Catheter
5.2.1.3.3. Others
5.2.2. Usage, Value (USD Million)
5.2.2.1. Urine Collection Bags
5.2.2.1.1. Disposable
5.2.2.1.2. Reusable
5.2.2.2. Urine Catheter
5.2.2.2.1. Disposable
5.2.2.2.2. Reusable
5.2.3. Medical Condition, Value (USD Million)
5.2.3.1. Chronic Kidney Disease (CKD)
5.2.3.2. Acute Kidney Injury
5.2.3.3. Post-Surgical & Intensive Care
5.2.3.4. Sepsis and Shock
5.2.3.5. Others
5.2.4. End user, Value (USD Million)
5.2.4.1. Hospital & Clinics
5.2.4.2. Diagnostic Laboratories
5.2.4.3. Others
5.2.5. Regional Synopsis (USD Million), 2024-2037
5.2.5.1. North America, Value (USD Million)
5.2.5.2. Europe, Value (USD Million)
5.2.5.3. Asia Pacific, Value (USD Million)
5.2.5.4. Latin America, Value (USD Million)
5.2.5.5. Middle East and Africa, Value (USD Million)
6. North America Market
6.1. Overview
6.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
6.1.2. Increment $ Opportunity Assessment, 2024-2037
6.1.3. Year-on-Year Growth Forecast (%)
6.2. Segmentation (USD Million), 2024-2037, By
6.2.1. Product Type, Value (USD Million)
6.2.1.1. Urine Output Monitoring Systems
6.2.1.1.1. Automated Urine Output Monitors
6.2.1.1.2. Manual Urine Output Monitors
6.2.1.1.3. Smart Urine Output Monitoring Devices
6.2.1.2. Urine Analysis Monitoring Systems
6.2.1.2.1. Automated Urine Analyzer
6.2.1.2.2. Semi-Automated Urine Analyzer
6.2.1.2.3. Point-of-Care Urine Analyzer
6.2.1.2.4. Non-Invasive Urine Monitoring System
6.2.1.3. Urine Collection Devices
6.2.1.3.1. Urine Collection Bags
6.2.1.3.2. Urinary Catheter
6.2.1.3.3. Others
6.2.2. Usage, Value (USD Million)
6.2.2.1. Urine Collection Bags
6.2.2.1.1. Disposable
6.2.2.1.2. Reusable
6.2.2.2. Urine Catheter
6.2.2.2.1. Disposable
6.2.2.2.2. Reusable
6.2.3. Medical Condition, Value (USD Million)
6.2.3.1. Chronic Kidney Disease (CKD)
6.2.3.2. Acute Kidney Injury
6.2.3.3. Post-Surgical & Intensive Care
6.2.3.4. Sepsis and Shock
6.2.3.5. Others
6.2.4. End user, Value (USD Million)
6.2.4.1. Hospital & Clinics
6.2.4.2. Diagnostic Laboratories
6.2.4.3. Others
6.2.5. Country Level Analysis, Value (USD Million)
6.2.5.1. U.S.
6.2.5.2. Canada
6.3. U.S. Market
6.3.1. Overview
6.3.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
6.3.1.2. Increment $ Opportunity Assessment, 2024-2037
6.3.1.3. Year-on-Year Growth Forecast (%)
6.3.2. Segmentation (USD Million), 2024-2037, By
6.3.2.1. Product Type, Value (USD Million)
6.3.2.1.1. Urine Output Monitoring Systems
6.3.2.1.1.1. Automated Urine Output Monitors
6.3.2.1.1.2. Manual Urine Output Monitors
6.3.2.1.1.3. Smart Urine Output Monitoring Devices
6.3.2.1.2. Urine Analysis Monitoring Systems
6.3.2.1.2.1. Automated Urine Analyzer
6.3.2.1.2.2. Semi-Automated Urine Analyzer
6.3.2.1.2.3. Point-of-Care Urine Analyzer
6.3.2.1.2.4. Non-Invasive Urine Monitoring System
6.3.2.1.3. Urine Collection Devices
6.3.2.1.3.1. Urine Collection Bags
6.3.2.1.3.2. Urinary Catheter
6.3.2.1.3.3. Others
6.3.2.2. Usage, Value (USD Million)
6.3.2.2.1. Urine Collection Bags
6.3.2.2.1.1. Disposable
6.3.2.2.1.2. Reusable
6.3.2.2.2. Urine Catheter
6.3.2.2.2.1. Disposable
6.3.2.2.2.2. Reusable
6.3.2.3. Medical Condition, Value (USD Million)
6.3.2.3.1. Chronic Kidney Disease (CKD)
6.3.2.3.2. Acute Kidney Injury
6.3.2.3.3. Post-Surgical & Intensive Care
6.3.2.3.4. Sepsis and Shock
6.3.2.3.5. Others
6.3.2.4. End user, Value (USD Million)
6.3.2.4.1. Hospital & Clinics
6.3.2.4.2. Diagnostic Laboratories
6.3.2.4.3. Others
6.3.3. U.S. Industry Overview
6.3.3.1. U.S. Urine Monitoring Systems Market Outlook
6.3.3.2. DROT
6.3.3.2.1. Driver
6.3.3.2.2. Restraint
6.3.3.2.3. Opportunities
6.3.3.2.4. Trends
6.3.3.3. Government Regulation
6.3.3.4. Competitive Landscape
6.3.3.5. Market Share in the U.S. - By Product Type
6.3.3.6. Automatic Urine Output Monitoring Devices - By Medical Condition
6.3.3.7. End user Analysis
6.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
6.1.2. Increment $ Opportunity Assessment, 2024-2037
6.1.3. Year-on-Year Growth Forecast (%)
6.2. Segmentation (USD Million), 2024-2037, By
6.2.1. Product Type, Value (USD Million)
6.2.1.1. Urine Output Monitoring Systems
6.2.1.1.1. Automated Urine Output Monitors
6.2.1.1.2. Manual Urine Output Monitors
6.2.1.1.3. Smart Urine Output Monitoring Devices
6.2.1.2. Urine Analysis Monitoring Systems
6.2.1.2.1. Automated Urine Analyzer
6.2.1.2.2. Semi-Automated Urine Analyzer
6.2.1.2.3. Point-of-Care Urine Analyzer
6.2.1.2.4. Non-Invasive Urine Monitoring System
6.2.1.3. Urine Collection Devices
6.2.1.3.1. Urine Collection Bags
6.2.1.3.2. Urinary Catheter
6.2.1.3.3. Others
6.2.2. Usage, Value (USD Million)
6.2.2.1. Urine Collection Bags
6.2.2.1.1. Disposable
6.2.2.1.2. Reusable
6.2.2.2. Urine Catheter
6.2.2.2.1. Disposable
6.2.2.2.2. Reusable
6.2.3. Medical Condition, Value (USD Million)
6.2.3.1. Chronic Kidney Disease (CKD)
6.2.3.2. Acute Kidney Injury
6.2.3.3. Post-Surgical & Intensive Care
6.2.3.4. Sepsis and Shock
6.2.3.5. Others
6.2.4. End user, Value (USD Million)
6.2.4.1. Hospital & Clinics
6.2.4.2. Diagnostic Laboratories
6.2.4.3. Others
6.2.5. Country Level Analysis, Value (USD Million)
6.2.5.1. U.S.
6.2.5.2. Canada
6.3. U.S. Market
6.3.1. Overview
6.3.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
6.3.1.2. Increment $ Opportunity Assessment, 2024-2037
6.3.1.3. Year-on-Year Growth Forecast (%)
6.3.2. Segmentation (USD Million), 2024-2037, By
6.3.2.1. Product Type, Value (USD Million)
6.3.2.1.1. Urine Output Monitoring Systems
6.3.2.1.1.1. Automated Urine Output Monitors
6.3.2.1.1.2. Manual Urine Output Monitors
6.3.2.1.1.3. Smart Urine Output Monitoring Devices
6.3.2.1.2. Urine Analysis Monitoring Systems
6.3.2.1.2.1. Automated Urine Analyzer
6.3.2.1.2.2. Semi-Automated Urine Analyzer
6.3.2.1.2.3. Point-of-Care Urine Analyzer
6.3.2.1.2.4. Non-Invasive Urine Monitoring System
6.3.2.1.3. Urine Collection Devices
6.3.2.1.3.1. Urine Collection Bags
6.3.2.1.3.2. Urinary Catheter
6.3.2.1.3.3. Others
6.3.2.2. Usage, Value (USD Million)
6.3.2.2.1. Urine Collection Bags
6.3.2.2.1.1. Disposable
6.3.2.2.1.2. Reusable
6.3.2.2.2. Urine Catheter
6.3.2.2.2.1. Disposable
6.3.2.2.2.2. Reusable
6.3.2.3. Medical Condition, Value (USD Million)
6.3.2.3.1. Chronic Kidney Disease (CKD)
6.3.2.3.2. Acute Kidney Injury
6.3.2.3.3. Post-Surgical & Intensive Care
6.3.2.3.4. Sepsis and Shock
6.3.2.3.5. Others
6.3.2.4. End user, Value (USD Million)
6.3.2.4.1. Hospital & Clinics
6.3.2.4.2. Diagnostic Laboratories
6.3.2.4.3. Others
6.3.3. U.S. Industry Overview
6.3.3.1. U.S. Urine Monitoring Systems Market Outlook
6.3.3.2. DROT
6.3.3.2.1. Driver
6.3.3.2.2. Restraint
6.3.3.2.3. Opportunities
6.3.3.2.4. Trends
6.3.3.3. Government Regulation
6.3.3.4. Competitive Landscape
6.3.3.5. Market Share in the U.S. - By Product Type
6.3.3.6. Automatic Urine Output Monitoring Devices - By Medical Condition
6.3.3.7. End user Analysis
7. Europe Market
7.1. Overview
7.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
7.1.2. Increment $ Opportunity Assessment, 2024-2037
7.1.3. Year-on-Year Growth Forecast (%)
7.2. Segmentation (USD Million), 2024-2037, By
7.2.1. Product Type, Value (USD Million)
7.2.1.1. Urine Output Monitoring Systems
7.2.1.1.1. Automated Urine Output Monitors
7.2.1.1.2. Manual Urine Output Monitors
7.2.1.1.3. Smart Urine Output Monitoring Devices
7.2.1.2. Urine Analysis Monitoring Systems
7.2.1.2.1. Automated Urine Analyzer
7.2.1.2.2. Semi-Automated Urine Analyzer
7.2.1.2.3. Point-of-Care Urine Analyzer
7.2.1.2.4. Non-Invasive Urine Monitoring System
7.2.1.3. Urine Collection Devices
7.2.1.3.1. Urine Collection Bags
7.2.1.3.2. Urinary Catheter
7.2.1.3.3. Others
7.2.2. Usage, Value (USD Million)
7.2.2.1. Urine Collection Bags
7.2.2.1.1. Disposable
7.2.2.1.2. Reusable
7.2.2.2. Urine Catheter
7.2.2.2.1. Disposable
7.2.2.2.2. Reusable
7.2.3. Medical Condition, Value (USD Million)
7.2.3.1. Chronic Kidney Disease (CKD)
7.2.3.2. Acute Kidney Injury
7.2.3.3. Post-Surgical & Intensive Care
7.2.3.4. Sepsis and Shock
7.2.3.5. Others
7.2.4. End user, Value (USD Million)
7.2.4.1. Hospital & Clinics
7.2.4.2. Diagnostic Laboratories
7.2.4.3. Others
7.2.5. Country Level Analysis, Value (USD Million)
7.2.5.1. UK
7.2.5.2. Germany
7.2.5.3. France
7.2.5.4. Italy
7.2.5.5. Spain
7.2.5.6. NORDIC
7.2.5.7. Russia
7.2.5.8. Rest of Europe
7.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
7.1.2. Increment $ Opportunity Assessment, 2024-2037
7.1.3. Year-on-Year Growth Forecast (%)
7.2. Segmentation (USD Million), 2024-2037, By
7.2.1. Product Type, Value (USD Million)
7.2.1.1. Urine Output Monitoring Systems
7.2.1.1.1. Automated Urine Output Monitors
7.2.1.1.2. Manual Urine Output Monitors
7.2.1.1.3. Smart Urine Output Monitoring Devices
7.2.1.2. Urine Analysis Monitoring Systems
7.2.1.2.1. Automated Urine Analyzer
7.2.1.2.2. Semi-Automated Urine Analyzer
7.2.1.2.3. Point-of-Care Urine Analyzer
7.2.1.2.4. Non-Invasive Urine Monitoring System
7.2.1.3. Urine Collection Devices
7.2.1.3.1. Urine Collection Bags
7.2.1.3.2. Urinary Catheter
7.2.1.3.3. Others
7.2.2. Usage, Value (USD Million)
7.2.2.1. Urine Collection Bags
7.2.2.1.1. Disposable
7.2.2.1.2. Reusable
7.2.2.2. Urine Catheter
7.2.2.2.1. Disposable
7.2.2.2.2. Reusable
7.2.3. Medical Condition, Value (USD Million)
7.2.3.1. Chronic Kidney Disease (CKD)
7.2.3.2. Acute Kidney Injury
7.2.3.3. Post-Surgical & Intensive Care
7.2.3.4. Sepsis and Shock
7.2.3.5. Others
7.2.4. End user, Value (USD Million)
7.2.4.1. Hospital & Clinics
7.2.4.2. Diagnostic Laboratories
7.2.4.3. Others
7.2.5. Country Level Analysis, Value (USD Million)
7.2.5.1. UK
7.2.5.2. Germany
7.2.5.3. France
7.2.5.4. Italy
7.2.5.5. Spain
7.2.5.6. NORDIC
7.2.5.7. Russia
7.2.5.8. Rest of Europe
8. Asia Pacific Market
8.1. Overview
8.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
8.1.2. Increment $ Opportunity Assessment, 2024-2037
8.1.3. Year-on-Year Growth Forecast (%)
8.2. Segmentation (USD Million), 2024-2037, By
8.2.1. Product Type, Value (USD Million)
8.2.1.1. Urine Output Monitoring Systems
8.2.1.1.1. Automated Urine Output Monitors
8.2.1.1.2. Manual Urine Output Monitors
8.2.1.1.3. Smart Urine Output Monitoring Devices
8.2.1.2. Urine Analysis Monitoring Systems
8.2.1.2.1. Automated Urine Analyzer
8.2.1.2.2. Semi-Automated Urine Analyzer
8.2.1.2.3. Point-of-Care Urine Analyzer
8.2.1.2.4. Non-Invasive Urine Monitoring System
8.2.1.3. Urine Collection Devices
8.2.1.3.1. Urine Collection Bags
8.2.1.3.2. Urinary Catheter
8.2.1.3.3. Others
8.2.2. Usage, Value (USD Million)
8.2.2.1. Urine Collection Bags
8.2.2.1.1. Disposable
8.2.2.1.2. Reusable
8.2.2.2. Urine Catheter
8.2.2.2.1. Disposable
8.2.2.2.2. Reusable
8.2.3. Medical Condition, Value (USD Million)
8.2.3.1. Chronic Kidney Disease (CKD)
8.2.3.2. Acute Kidney Injury
8.2.3.3. Post-Surgical & Intensive Care
8.2.3.4. Sepsis and Shock
8.2.3.5. Others
8.2.4. End user, Value (USD Million)
8.2.4.1. Hospital & Clinics
8.2.4.2. Diagnostic Laboratories
8.2.4.3. Others
8.2.5. Country Level Analysis, Value (USD Million)
8.2.5.1. China
8.2.5.2. India
8.2.5.3. Japan
8.2.5.4. South Korea
8.2.5.5. Australia
8.2.5.6. Singapore
8.2.5.7. Malaysia
8.2.5.8. Thailand
8.2.5.9. Vietnam
8.2.5.10. Rest of Asia Pacific
8.3. China Market
8.3.1. Overview
8.3.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
8.3.1.2. Increment $ Opportunity Assessment, 2024-2037
8.3.1.3. Year-on-Year Growth Forecast (%)
8.3.2. Segmentation (USD Million), 2024-2037, By
8.3.2.1. Product Type, Value (USD Million)
8.3.2.1.1. Urine Output Monitoring Systems
8.3.2.1.1.1. Automated Urine Output Monitors
8.3.2.1.1.2. Manual Urine Output Monitors
8.3.2.1.1.3. Smart Urine Output Monitoring Devices
8.3.2.1.2. Urine Analysis Monitoring Systems
8.3.2.1.2.1. Automated Urine Analyzer
8.3.2.1.2.2. Semi-Automated Urine Analyzer
8.3.2.1.2.3. Point-of-Care Urine Analyzer
8.3.2.1.2.4. Non-Invasive Urine Monitoring System
8.3.2.1.3. Urine Collection Devices
8.3.2.1.3.1. Urine Collection Bags
8.3.2.1.3.2. Urinary Catheter
8.3.2.1.3.3. Others
8.3.2.2. Usage, Value (USD Million)
8.3.2.2.1. Urine Collection Bags
8.3.2.2.1.1. Disposable
8.3.2.2.1.2. Reusable
8.3.2.2.2. Urine Catheter
8.3.2.2.2.1. Disposable
8.3.2.2.2.2. Reusable
8.3.2.3. Medical Condition, Value (USD Million)
8.3.2.3.1. Chronic Kidney Disease (CKD)
8.3.2.3.2. Acute Kidney Injury
8.3.2.3.3. Post-Surgical & Intensive Care
8.3.2.3.4. Sepsis and Shock
8.3.2.3.5. Others
8.3.2.4. End user, Value (USD Million)
8.3.2.4.1. Hospital & Clinics
8.3.2.4.2. Diagnostic Laboratories
8.3.2.4.3. Others
8.3.3. China Industry Overview
8.3.3.1. China Urine Monitoring Systems Market Outlook
8.3.3.2. DROT
8.3.3.2.1. Driver
8.3.3.2.2. Restraint
8.3.3.2.3. Opportunities
8.3.3.2.4. Trends
8.3.3.3. Government Regulation
8.3.3.4. Competitive Landscape
8.3.3.5. Market Share in China - By Product Type
8.3.3.6. Automatic Urine Output Monitoring Devices - By Medical Condition
8.3.3.7. End user Analysis
8.4. Japan Market
8.4.1. Overview
8.4.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
8.4.1.2. Increment $ Opportunity Assessment, 2024-2037
8.4.1.3. Year-on-Year Growth Forecast (%)
8.4.2. Segmentation (USD Million), 2024-2037, By
8.4.2.1. Product Type, Value (USD Million)
8.4.2.1.1. Urine Output Monitoring Systems
8.4.2.1.1.1. Automated Urine Output Monitors
8.4.2.1.1.2. Manual Urine Output Monitors
8.4.2.1.1.3. Smart Urine Output Monitoring Devices
8.4.2.1.2. Urine Analysis Monitoring Systems
8.4.2.1.2.1. Automated Urine Analyzer
8.4.2.1.2.2. Semi-Automated Urine Analyzer
8.4.2.1.2.3. Point-of-Care Urine Analyzer
8.4.2.1.2.4. Non-Invasive Urine Monitoring System
8.4.2.1.3. Urine Collection Devices
8.4.2.1.3.1. Urine Collection Bags
8.4.2.1.3.2. Urinary Catheter
8.4.2.1.3.3. Others
8.4.2.2. Usage, Value (USD Million)
8.4.2.2.1. Urine Collection Bags
8.4.2.2.1.1. Disposable
8.4.2.2.1.2. Reusable
8.4.2.2.2. Urine Catheter
8.4.2.2.2.1. Disposable
8.4.2.2.2.2. Reusable
8.4.2.3. Medical Condition, Value (USD Million)
8.4.2.3.1. Chronic Kidney Disease (CKD)
8.4.2.3.2. Acute Kidney Injury
8.4.2.3.3. Post-Surgical & Intensive Care
8.4.2.3.4. Sepsis and Shock
8.4.2.3.5. Others
8.4.2.4. End user, Value (USD Million)
8.4.2.4.1. Hospital & Clinics
8.4.2.4.2. Diagnostic Laboratories
8.4.2.4.3. Others
8.4.3. Japan Industry Overview
8.4.3.1. Japan Urine Monitoring Systems Market Outlook
8.4.3.2. DROT
8.4.3.2.1. Driver
8.4.3.2.2. Restraint
8.4.3.2.3. Opportunities
8.4.3.2.4. Trends
8.4.3.3. Government Regulation
8.4.3.4. Competitive Landscape
8.4.3.5. Market Share in Japan- By Product Type
8.4.3.6. Automatic Urine Output Monitoring Devices - By Medical Condition
8.4.3.7. End user Analysis
8.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
8.1.2. Increment $ Opportunity Assessment, 2024-2037
8.1.3. Year-on-Year Growth Forecast (%)
8.2. Segmentation (USD Million), 2024-2037, By
8.2.1. Product Type, Value (USD Million)
8.2.1.1. Urine Output Monitoring Systems
8.2.1.1.1. Automated Urine Output Monitors
8.2.1.1.2. Manual Urine Output Monitors
8.2.1.1.3. Smart Urine Output Monitoring Devices
8.2.1.2. Urine Analysis Monitoring Systems
8.2.1.2.1. Automated Urine Analyzer
8.2.1.2.2. Semi-Automated Urine Analyzer
8.2.1.2.3. Point-of-Care Urine Analyzer
8.2.1.2.4. Non-Invasive Urine Monitoring System
8.2.1.3. Urine Collection Devices
8.2.1.3.1. Urine Collection Bags
8.2.1.3.2. Urinary Catheter
8.2.1.3.3. Others
8.2.2. Usage, Value (USD Million)
8.2.2.1. Urine Collection Bags
8.2.2.1.1. Disposable
8.2.2.1.2. Reusable
8.2.2.2. Urine Catheter
8.2.2.2.1. Disposable
8.2.2.2.2. Reusable
8.2.3. Medical Condition, Value (USD Million)
8.2.3.1. Chronic Kidney Disease (CKD)
8.2.3.2. Acute Kidney Injury
8.2.3.3. Post-Surgical & Intensive Care
8.2.3.4. Sepsis and Shock
8.2.3.5. Others
8.2.4. End user, Value (USD Million)
8.2.4.1. Hospital & Clinics
8.2.4.2. Diagnostic Laboratories
8.2.4.3. Others
8.2.5. Country Level Analysis, Value (USD Million)
8.2.5.1. China
8.2.5.2. India
8.2.5.3. Japan
8.2.5.4. South Korea
8.2.5.5. Australia
8.2.5.6. Singapore
8.2.5.7. Malaysia
8.2.5.8. Thailand
8.2.5.9. Vietnam
8.2.5.10. Rest of Asia Pacific
8.3. China Market
8.3.1. Overview
8.3.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
8.3.1.2. Increment $ Opportunity Assessment, 2024-2037
8.3.1.3. Year-on-Year Growth Forecast (%)
8.3.2. Segmentation (USD Million), 2024-2037, By
8.3.2.1. Product Type, Value (USD Million)
8.3.2.1.1. Urine Output Monitoring Systems
8.3.2.1.1.1. Automated Urine Output Monitors
8.3.2.1.1.2. Manual Urine Output Monitors
8.3.2.1.1.3. Smart Urine Output Monitoring Devices
8.3.2.1.2. Urine Analysis Monitoring Systems
8.3.2.1.2.1. Automated Urine Analyzer
8.3.2.1.2.2. Semi-Automated Urine Analyzer
8.3.2.1.2.3. Point-of-Care Urine Analyzer
8.3.2.1.2.4. Non-Invasive Urine Monitoring System
8.3.2.1.3. Urine Collection Devices
8.3.2.1.3.1. Urine Collection Bags
8.3.2.1.3.2. Urinary Catheter
8.3.2.1.3.3. Others
8.3.2.2. Usage, Value (USD Million)
8.3.2.2.1. Urine Collection Bags
8.3.2.2.1.1. Disposable
8.3.2.2.1.2. Reusable
8.3.2.2.2. Urine Catheter
8.3.2.2.2.1. Disposable
8.3.2.2.2.2. Reusable
8.3.2.3. Medical Condition, Value (USD Million)
8.3.2.3.1. Chronic Kidney Disease (CKD)
8.3.2.3.2. Acute Kidney Injury
8.3.2.3.3. Post-Surgical & Intensive Care
8.3.2.3.4. Sepsis and Shock
8.3.2.3.5. Others
8.3.2.4. End user, Value (USD Million)
8.3.2.4.1. Hospital & Clinics
8.3.2.4.2. Diagnostic Laboratories
8.3.2.4.3. Others
8.3.3. China Industry Overview
8.3.3.1. China Urine Monitoring Systems Market Outlook
8.3.3.2. DROT
8.3.3.2.1. Driver
8.3.3.2.2. Restraint
8.3.3.2.3. Opportunities
8.3.3.2.4. Trends
8.3.3.3. Government Regulation
8.3.3.4. Competitive Landscape
8.3.3.5. Market Share in China - By Product Type
8.3.3.6. Automatic Urine Output Monitoring Devices - By Medical Condition
8.3.3.7. End user Analysis
8.4. Japan Market
8.4.1. Overview
8.4.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
8.4.1.2. Increment $ Opportunity Assessment, 2024-2037
8.4.1.3. Year-on-Year Growth Forecast (%)
8.4.2. Segmentation (USD Million), 2024-2037, By
8.4.2.1. Product Type, Value (USD Million)
8.4.2.1.1. Urine Output Monitoring Systems
8.4.2.1.1.1. Automated Urine Output Monitors
8.4.2.1.1.2. Manual Urine Output Monitors
8.4.2.1.1.3. Smart Urine Output Monitoring Devices
8.4.2.1.2. Urine Analysis Monitoring Systems
8.4.2.1.2.1. Automated Urine Analyzer
8.4.2.1.2.2. Semi-Automated Urine Analyzer
8.4.2.1.2.3. Point-of-Care Urine Analyzer
8.4.2.1.2.4. Non-Invasive Urine Monitoring System
8.4.2.1.3. Urine Collection Devices
8.4.2.1.3.1. Urine Collection Bags
8.4.2.1.3.2. Urinary Catheter
8.4.2.1.3.3. Others
8.4.2.2. Usage, Value (USD Million)
8.4.2.2.1. Urine Collection Bags
8.4.2.2.1.1. Disposable
8.4.2.2.1.2. Reusable
8.4.2.2.2. Urine Catheter
8.4.2.2.2.1. Disposable
8.4.2.2.2.2. Reusable
8.4.2.3. Medical Condition, Value (USD Million)
8.4.2.3.1. Chronic Kidney Disease (CKD)
8.4.2.3.2. Acute Kidney Injury
8.4.2.3.3. Post-Surgical & Intensive Care
8.4.2.3.4. Sepsis and Shock
8.4.2.3.5. Others
8.4.2.4. End user, Value (USD Million)
8.4.2.4.1. Hospital & Clinics
8.4.2.4.2. Diagnostic Laboratories
8.4.2.4.3. Others
8.4.3. Japan Industry Overview
8.4.3.1. Japan Urine Monitoring Systems Market Outlook
8.4.3.2. DROT
8.4.3.2.1. Driver
8.4.3.2.2. Restraint
8.4.3.2.3. Opportunities
8.4.3.2.4. Trends
8.4.3.3. Government Regulation
8.4.3.4. Competitive Landscape
8.4.3.5. Market Share in Japan- By Product Type
8.4.3.6. Automatic Urine Output Monitoring Devices - By Medical Condition
8.4.3.7. End user Analysis
9. Latin America Market
9.1. Overview
9.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
9.1.2. Increment $ Opportunity Assessment, 2024-2037
9.1.3. Year-on-Year Growth Forecast (%)
9.2. Segmentation (USD Million), 2024-2037, By
9.2.1. Product Type, Value (USD Million)
9.2.1.1. Urine Output Monitoring Systems
9.2.1.1.1. Automated Urine Output Monitors
9.2.1.1.2. Manual Urine Output Monitors
9.2.1.1.3. Smart Urine Output Monitoring Devices
9.2.1.2. Urine Analysis Monitoring Systems
9.2.1.2.1. Automated Urine Analyzer
9.2.1.2.2. Semi-Automated Urine Analyzer
9.2.1.2.3. Point-of-Care Urine Analyzer
9.2.1.2.4. Non-Invasive Urine Monitoring System
9.2.1.3. Urine Collection Devices
9.2.1.3.1. Urine Collection Bags
9.2.1.3.2. Urinary Catheter
9.2.1.3.3. Others
9.2.2. Usage, Value (USD Million)
9.2.2.1. Urine Collection Bags
9.2.2.1.1. Disposable
9.2.2.1.2. Reusable
9.2.2.2. Urine Catheter
9.2.2.2.1. Disposable
9.2.2.2.2. Reusable
9.2.3. Medical Condition, Value (USD Million)
9.2.3.1. Chronic Kidney Disease (CKD)
9.2.3.2. Acute Kidney Injury
9.2.3.3. Post-Surgical & Intensive Care
9.2.3.4. Sepsis and Shock
9.2.3.5. Others
9.2.4. End user, Value (USD Million)
9.2.4.1. Hospital & Clinics
9.2.4.2. Diagnostic Laboratories
9.2.4.3. Others
9.2.5. Country Level Analysis, Value (USD Million)
9.2.5.1. Brazil
9.2.5.2. Mexico
9.2.5.3. Argentina
9.2.5.4. Rest of Latin America
9.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
9.1.2. Increment $ Opportunity Assessment, 2024-2037
9.1.3. Year-on-Year Growth Forecast (%)
9.2. Segmentation (USD Million), 2024-2037, By
9.2.1. Product Type, Value (USD Million)
9.2.1.1. Urine Output Monitoring Systems
9.2.1.1.1. Automated Urine Output Monitors
9.2.1.1.2. Manual Urine Output Monitors
9.2.1.1.3. Smart Urine Output Monitoring Devices
9.2.1.2. Urine Analysis Monitoring Systems
9.2.1.2.1. Automated Urine Analyzer
9.2.1.2.2. Semi-Automated Urine Analyzer
9.2.1.2.3. Point-of-Care Urine Analyzer
9.2.1.2.4. Non-Invasive Urine Monitoring System
9.2.1.3. Urine Collection Devices
9.2.1.3.1. Urine Collection Bags
9.2.1.3.2. Urinary Catheter
9.2.1.3.3. Others
9.2.2. Usage, Value (USD Million)
9.2.2.1. Urine Collection Bags
9.2.2.1.1. Disposable
9.2.2.1.2. Reusable
9.2.2.2. Urine Catheter
9.2.2.2.1. Disposable
9.2.2.2.2. Reusable
9.2.3. Medical Condition, Value (USD Million)
9.2.3.1. Chronic Kidney Disease (CKD)
9.2.3.2. Acute Kidney Injury
9.2.3.3. Post-Surgical & Intensive Care
9.2.3.4. Sepsis and Shock
9.2.3.5. Others
9.2.4. End user, Value (USD Million)
9.2.4.1. Hospital & Clinics
9.2.4.2. Diagnostic Laboratories
9.2.4.3. Others
9.2.5. Country Level Analysis, Value (USD Million)
9.2.5.1. Brazil
9.2.5.2. Mexico
9.2.5.3. Argentina
9.2.5.4. Rest of Latin America
10. Middle East & Africa Market
10.1. Overview
10.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
10.1.2. Increment $ Opportunity Assessment, 2024-2037
10.1.3. Year-on-Year Growth Forecast (%)
10.2. Segmentation (USD Million), 2024-2037, By
10.2.1. Product Type, Value (USD Million)
10.2.1.1. Urine Output Monitoring Systems
10.2.1.1.1. Automated Urine Output Monitors
10.2.1.1.2. Manual Urine Output Monitors
10.2.1.1.3. Smart Urine Output Monitoring Devices
10.2.1.2. Urine Analysis Monitoring Systems
10.2.1.2.1. Automated Urine Analyzer
10.2.1.2.2. Semi-Automated Urine Analyzer
10.2.1.2.3. Point-of-Care Urine Analyzer
10.2.1.2.4. Non-Invasive Urine Monitoring System
10.2.1.3. Urine Collection Devices
10.2.1.3.1. Urine Collection Bags
10.2.1.3.2. Urinary Catheter
10.2.1.3.3. Others
10.2.2. Usage, Value (USD Million)
10.2.2.1. Urine Collection Bags
10.2.2.1.1. Disposable
10.2.2.1.2. Reusable
10.2.2.2. Urine Catheter
10.2.2.2.1. Disposable
10.2.2.2.2. Reusable
10.2.3. Medical Condition, Value (USD Million)
10.2.3.1. Chronic Kidney Disease (CKD)
10.2.3.2. Acute Kidney Injury
10.2.3.3. Post-Surgical & Intensive Care
10.2.3.4. Sepsis and Shock
10.2.3.5. Others
10.2.4. End user, Value (USD Million)
10.2.4.1. Hospital & Clinics
10.2.4.2. Diagnostic Laboratories
10.2.4.3. Others
10.2.5. Country Level Analysis, Value (USD Million)
10.2.5.1. GCC
10.2.5.2. Israel
10.2.5.3. South Africa
10.2.5.4. Rest of Middle East & Africa
10.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
10.1.2. Increment $ Opportunity Assessment, 2024-2037
10.1.3. Year-on-Year Growth Forecast (%)
10.2. Segmentation (USD Million), 2024-2037, By
10.2.1. Product Type, Value (USD Million)
10.2.1.1. Urine Output Monitoring Systems
10.2.1.1.1. Automated Urine Output Monitors
10.2.1.1.2. Manual Urine Output Monitors
10.2.1.1.3. Smart Urine Output Monitoring Devices
10.2.1.2. Urine Analysis Monitoring Systems
10.2.1.2.1. Automated Urine Analyzer
10.2.1.2.2. Semi-Automated Urine Analyzer
10.2.1.2.3. Point-of-Care Urine Analyzer
10.2.1.2.4. Non-Invasive Urine Monitoring System
10.2.1.3. Urine Collection Devices
10.2.1.3.1. Urine Collection Bags
10.2.1.3.2. Urinary Catheter
10.2.1.3.3. Others
10.2.2. Usage, Value (USD Million)
10.2.2.1. Urine Collection Bags
10.2.2.1.1. Disposable
10.2.2.1.2. Reusable
10.2.2.2. Urine Catheter
10.2.2.2.1. Disposable
10.2.2.2.2. Reusable
10.2.3. Medical Condition, Value (USD Million)
10.2.3.1. Chronic Kidney Disease (CKD)
10.2.3.2. Acute Kidney Injury
10.2.3.3. Post-Surgical & Intensive Care
10.2.3.4. Sepsis and Shock
10.2.3.5. Others
10.2.4. End user, Value (USD Million)
10.2.4.1. Hospital & Clinics
10.2.4.2. Diagnostic Laboratories
10.2.4.3. Others
10.2.5. Country Level Analysis, Value (USD Million)
10.2.5.1. GCC
10.2.5.2. Israel
10.2.5.3. South Africa
10.2.5.4. Rest of Middle East & Africa
11. Global Economic Scenario
11.1. World Economic Outlook
12. About the Publisher
12.1. Global Clientele
Companies Mentioned
- Accuryn Medical
- BECTON
- DICKINSON AND COMPANY
- Beckman Coulter Inc.
- Cardinal Health
- DiaSys Diagnostics India Pvt Ltd
- F. Hoffmann-La Roche Ltd
- FIZE Medical
- Hollister Incorporated
- Laborie
